RankingsPricing
  1. JP-listed companies
  2. Pharmarise Holdings Corporation
  3. Financials
  4. Operating expenses

Pharmarise Holdings CorporationJP:2796

Market cap
¥6.4B
P/E ratio
22.6x
SummaryFinancialsHistorySegmentsOwnershipWorkforce
Period EndOperating expenses (Million JPY)YoY (%)
May 31, 20258,671+15.11%
May 31, 20247,533+12.52%
May 31, 20236,695+1.50%
May 31, 20226,596-3.30%
May 31, 20216,821+6.54%
May 31, 20206,402-4.48%
May 31, 20196,702-1.02%
May 31, 20186,771-0.06%
May 31, 20176,775+10.76%
May 31, 20166,117+16.90%
May 31, 20155,232+17.85%
May 31, 20144,440

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)